Chimerix Profit Margin 2011-2019 | CMRX

Current and historical gross margin, operating margin and net profit margin for Chimerix (CMRX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Chimerix net profit margin as of March 31, 2019 is -729.02%.
Chimerix Annual Profit Margins
Chimerix Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.144B $0.007B
Chimerix, Inc. engages in the discovery, development and commercialization of oral antiviral therapeutics for various medical needs. The Company is developing various product candidates for the treatment of dsDNA viruses, HIV, hepatitis C, influenza and smallpox which are under different phases of clinical development. It is also screening our proprietary Chimerix Chemical Library for compounds with activity against dengue virus, malaria and tuberculosis. Chimerix, Inc. is headquartered in Durham, North Carolina.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.115B 28.03
Medtronic (MDT) Ireland $144.617B 20.31
Stryker (SYK) United States $81.656B 28.24
Boston Scientific (BSX) United States $59.466B 28.84
Baxter (BAX) United States $44.526B 27.00
EssilorLuxottica Societe Anonyme (ESLOY) France $31.586B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.151B 18.02
Coloplast (CLPBY) Denmark $26.697B 42.62
Lonza Group Ag (LZAGY) Switzerland $26.607B 0.00
Terumo (TRUMY) Japan $23.560B 27.09
Smith & Nephew SNATS (SNN) United Kingdom $20.735B 0.00
ResMed (RMD) United States $19.545B 37.27
Sunny Optical Technology (SNPTF) China $14.643B 0.00
Bio-Rad Laboratories (BIO) United States $10.190B 54.63
Insulet (PODD) United States $9.354B 554.25
Canopy Growth (CGC) Canada $8.712B 0.00
William Demant Holdings (WILYY) Denmark $7.136B 0.00
Hill-Rom Holdings (HRC) United States $7.062B 21.06
Haemonetics (HAE) United States $6.793B 51.26
Perrigo (PRGO) Ireland $6.499B 11.97
GN STORE NORD (GNNDY) Denmark $6.001B 30.65
Aurora Cannabis (ACB) Canada $5.891B 57.90
GW Pharmaceuticals (GWPH) United Kingdom $4.444B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $3.753B 62.43
ICU Medical (ICUI) United States $3.439B 22.31
NuVasive (NUVA) United States $3.400B 27.10
Hutchison China MediTech (HCM) China $2.737B 0.00
Quidel (QDEL) United States $2.520B 25.02
Agios Pharmaceuticals (AGIO) United States $2.458B 0.00
National Vision Holdings (EYE) United States $2.257B 48.71
Cardiovascular Systems (CSII) United States $1.754B 0.00
Aphria (APHA) $1.634B 0.00
Phibro Animal Health (PAHC) United States $1.288B 19.30
AtriCure (ATRC) United States $1.035B 0.00
VAREX IMAGING (VREX) United States $1.028B 23.68
Omeros (OMER) United States $0.992B 0.00
PetIQ (PETQ) United States $0.900B 21.27
NanoString Technologies (NSTG) United States $0.896B 0.00
Lantheus Holdings (LNTH) United States $0.885B 23.25
Eagle Pharmaceuticals (EGRX) United States $0.796B 20.29
Cerus (CERS) United States $0.758B 0.00
MacroGenics (MGNX) United States $0.739B 0.00
Quanterix (QTRX) United States $0.667B 0.00
LeMaitre Vascular (LMAT) United States $0.624B 37.00
Surmodics (SRDX) United States $0.600B 114.08
TG Therapeutics (TGTX) United States $0.596B 0.00
OraSure Technologies (OSUR) United States $0.439B 20.34
Meridian Bioscience (VIVO) United States $0.410B 12.81
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.398B 0.00
BioLife Solutions (BLFS) United States $0.394B 129.63
United Health Products (UEEC) United States $0.374B 0.00
Utah Medical Products (UTMD) United States $0.346B 25.35
Zynex (ZYXI) United States $0.317B 33.65
Owens & Minor (OMI) United States $0.303B 9.09
Bovie Medical (APYX) United States $0.250B 0.00
Vapotherm (VAPO) United States $0.225B 0.00
Cytosorbents (CTSO) United States $0.160B 0.00
Fonar (FONR) United States $0.155B 8.16
Rockwell Medical (RMTI) United States $0.152B 0.00
Female Health (VERU) United States $0.129B 0.00
United-Guardian (UG) United States $0.089B 21.08
Chembio Diagnostics (CEMI) United States $0.087B 0.00
Surface Oncology (SURF) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Nephros (NEPH) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Trinity Biotech (TRIB) Ireland $0.036B 0.00
Senestech (SNES) United States $0.028B 0.00
Valeritas Holdings (VLRX) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
GUARDION HEALTH (GHSI) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00